Cision Unveils “Inside PR 2026”: The Definitive Report on PR Trends, AI Adoption, and the Future of Communications
New research reveals how PR teams are adapting to resource pressures, media…
MICROIP Highlights AIVO Edge AI Platform at CES 2026, Enabling Scalable Deployment Across Transportation Security, Agriculture, and Autonomous Systems
LAS VEGAS, Jan. 6, 2026 /PRNewswire/ -- MICROIP Inc., a Taiwan-based provider…
Simplilearn Joins IndiaAI Mission to Accelerate AI Literacy for 10 Million Citizens
BANGALORE, India, Jan. 6, 2026 /PRNewswire/ -- Simplilearn, a leading global digital…
Pole Star Global launches Maritime Transparency Index — turning 25 years of maritime intelligence into instant vessel and voyage risk verdicts
LONDON, Jan. 6, 2026 /PRNewswire/ -- Pole Star Global, a world leader in…
Tomorrowland announces its first-ever Thailand edition, launching as a full-scale festival in December 2026
BANGKOK and ANTWERP, Belgium, Jan. 6, 2026 /PRNewswire/ -- Thailand is set to…
GIGABYTE Unleashes the Full Power of X3D Enabled AMD Ryzen 9000 Series Processors with AI-powered X3D Turbo Mode 2.0 at CES 2026
TAIPEI, Jan. 6, 2026 /PRNewswire/ -- At CES 2026, GIGABYTE is unlocking…
GIGABYTE Unveils “Refine & Define” Shaping Future of AI Computing at CES 2026
TAIPEI, Jan. 6, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand,…
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report
Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders…
Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys for the Treatment of ADHD
SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
SINGAPORE, Jan. 6, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell…
